Expert Q&A: Effects of Collaborative Care Models on Patient Satisfaction in Rheumatoid Arthritis

John M. Davis III, MD, MS, from the Mayo Clinic in Rochester, Minnesota, and Jennifer Gorman, MD, MPH, from The Polyclinic in Seattle, Washington, discuss ...

Chikungunya Virus: What Every Rheumatologist Should Know

Chikungunya virus has become a disease of global concern due to its potentially disabling consequences and its efficient transmission.

Pregnancy in Rheumatic Disease: Managing Potentially Teratogenic Medications

Petros Efthimiou, MD, a rheumatologist at NYU Langone Health, discusses how clinicians should approach prescribing potentially teratogenic drugs in pregnancy.

Comparing Tumor Necrosis Factor Inhibitors for RA and SpA: Overview & Expert Interview

They similarities and differences of anti-TNF drug function in RA and SpA are discussed in an expert interview.

Choosing the Right TNF Inhibitor Therapy for Rheumatoid Arthritis

There are important differences in TNFis for specific clinical conditions that recent research has made more apparent.

Improving Function Through Exercise in Rheumatoid Arthritis

Although recent pharmacologic advances have improved disease progression and prognosis in RA, a number of patients experience joint stiffness.

Pregnancy in Inflammatory Arthritis: What Your Patients Need to Know

Megan Clowse, MD, MPH, discusses 2 studies that examine reproductive health concerns in women with inflammatory rheumatic diseases.

Infection in Rheumatoid Arthritis and Antigen-Specific Immunotherapy

Continued research is needed to guide a clearer understanding of the role infectious agents, anticitrullinated protein antibodies, and antinative protein antibodies play in rheumatoid arthritis ...

MRI in Rheumatoid Arthritis: Assessing Disease Activity, Remission, Prognosis

MRI allows to show changes to bone and cartilage, and to discriminate these from fluid and soft tissues around the joints, making it a good ...

Rheumatoid Arthritis Drugs During Pregnancy and Lactation: A Review of Safety Guidelines

Only limited data is available regarding the safety of anti-rheumatic drugs in pregnancy.

Latest News

Decreased Muscle Performance Linked to Increased Disease Activity in Rheumatoid Arthritis

Decreased Muscle Performance Linked to Increased Disease Activity in Rheumatoid Arthritis

Poorer muscle performance composite scores are associated with increased Disease Activity Scores for 28 joints in patients with rheumatoid arthritis.

Effects of Certolizumab Pegol Exposure on Pregnancy Outcomes in Women With Rheumatic Disease

Effects of Certolizumab Pegol Exposure on Pregnancy Outcomes in Women With Rheumatic Disease

Researchers sought to provide information on pregnancy outcomes, including major congenital malformations and other maternal and fetal adverse outcomes, in women treated with certolizumab pegol.

FDA Advisory Committee Recommends Against Approval of Baricitinib at Higher Dose for RA

FDA Advisory Committee Recommends Against Approval of Baricitinib at Higher Dose for RA

The FDA advisory panel voted in favor of baricitinib for the treatment of rheumatoid arthritis, but only recommended approval of the 2 mg dose.

GI Safety Compared for NSAIDs in Patients With Arthritis

GI Safety Compared for NSAIDs in Patients With Arthritis

The randomized, double-blind, controlled trial (N=24,081) included patients with rheumatoid arthritis or osteoarthritis who required chronic NSAID treatment.

Certain RA Treatments Tied to Improvements in Blood Pressure

Certain RA Treatments Tied to Improvements in Blood Pressure

Certain disease-modifying therapies for rheumatoid arthritis may have a positive effect on blood pressure.

Biosimilar Etanercept SB4 May Decrease Disease Activity in Inflammatory Rheumatic Disease

Biosimilar Etanercept SB4 May Decrease Disease Activity in Inflammatory Rheumatic Disease

Nonmandatory transitioning from originator etanercept to biosimilar etanercept SB4 using a specifically designed communication strategy showed a slightly lower persistence rate and smaller decreases in disease activity.

Quality of Life in Rheumatoid Arthritis Improved With Filgotinib

Quality of Life in Rheumatoid Arthritis Improved With Filgotinib

The results of 2 randomized controlled trials showed that filgotinib improved quality of life when given in combination with methotrexate or as monotherapy in rheumatoid arthritis.

Higher Preoperative Disease Activity Linked to RA Flares After Arthroplasty

Higher Preoperative Disease Activity Linked to RA Flares After Arthroplasty

Higher preoperative disease activity increased risk for postoperative flares in patients with rheumatoid arthritis who underwent total hip arthroplasty or total knee arthroplasty.

Risk Factors for Oral Methotrexate Failure Identified in Inflammatory Polyarthritis

Risk Factors for Oral Methotrexate Failure Identified in Inflammatory Polyarthritis

Investigators sought to evaluate the rate and predictors of oral methotrexate failure.

Sirukumab Effective in Rheumatoid Arthritis Refractory to Methotrexate or Sulfasalazine

Sirukumab Effective in Rheumatoid Arthritis Refractory to Methotrexate or Sulfasalazine

In patients with rheumatoid arthritis refractory to methotrexate and sulfasalazine, sirukumab monotherapy is generally tolerable with measurable efficacy over the course of 52 weeks.

Latest Slideshows

Alcohol Use: Surveying Effects on the Body's Major Systems

Alcohol Use: Surveying Effects on the Body's Major Systems

The effects of alcohol on the body's systems are examined here, with both damaging and potentially protective effects being explored. ...

Ten Unusually Specific ICD-10 Codes

Ten Unusually Specific ICD-10 Codes

With nearly 70,000 ICD-10 diagnosis codes available to clinicians, things are bound to get interesting.

Role of Vitamin D in Rheumatoid Arthritis Pathogenesis

Role of Vitamin D in Rheumatoid Arthritis Pathogenesis

Increasing evidence indicates serum vitamin D levels and polymorphisms in enzymes involved in vitamin D metabolism can affect the risk ...

Mitigating Risk of Cardiovascular Disease in Rheumatoid Arthritis

Mitigating Risk of Cardiovascular Disease in Rheumatoid Arthritis

Patients with rheumatoid arthritis have an increased risk of developing cardiovascular disease (CVD) and CVD-related mortality compared with the general ...

Examining Patient-Reported Outcomes in Rheumatoid Arthritis

Examining Patient-Reported Outcomes in Rheumatoid Arthritis

Validation of a patient-report outcome instrument as an effective independent tool for measuring disease activity and treatment response may one ...

Sign Up for Free e-newsletters